Legacy Wealth Management (Idaho)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Legacy Wealth Management (Idaho)'s BMY Position: Q1 2026 in Review
Legacy Wealth Management (Idaho) opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 21 shares worth $1.27K. The stake represents ﹤0.01% of the portfolio and ranks #836 among its holdings. This is a return to the name: Legacy Wealth Management (Idaho) previously reported a position in BMY as recently as Q2 2025.
Legacy Wealth Management (Idaho) first reported a position in BMY in Q3 2024 and has held it in 5 quarters since. The position peaked at $12.5K in Q1 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Legacy Wealth Management (Idaho) held 21 shares of Bristol-Myers Squibb worth $1.27K as of Q1 2026.
- Bristol-Myers Squibb was a new Legacy Wealth Management (Idaho) position in Q1 2026.
- Bristol-Myers Squibb made up ﹤0.01% of Legacy Wealth Management (Idaho)'s portfolio in Q1 2026, its #836 holding.
- Legacy Wealth Management (Idaho) first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 5 quarters since.
- Legacy Wealth Management (Idaho)'s Bristol-Myers Squibb position peaked at $12.5K in Q1 2025.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Legacy Wealth Management (Idaho)'s 13F filing for Q1 2026, filed 7 May 2026.